The m(6)A methylation landscape, molecular characterization and clinical relevance in prostate adenocarcinoma

BACKGROUND: Despite the recent progress of therapeutic strategies in treating prostate cancer (PCa), the majority of patients still eventually relapse, experiencing dismal outcomes. Therefore, it is of utmost importance to identify novel viable targets to increase the effectiveness of treatment. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chao, Peng, Dongyi, Gan, Yu, Zhou, Lei, Hou, Weibin, Wang, Bingzhi, Yuan, Peng, Xiong, Wei, Wang, Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076583/
https://www.ncbi.nlm.nih.gov/pubmed/37033963
http://dx.doi.org/10.3389/fimmu.2023.1086907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076583/
https://www.ncbi.nlm.nih.gov/pubmed/37033963
http://dx.doi.org/10.3389/fimmu.2023.1086907

Ejemplares similares